PE
MEDP icon

PCM Encore’s Medpace MEDP Stock Holding History

PCM Encore’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
465
-4
-0.9% -$1.85K 0.04% 383
2026
Q1 		$225K Sell
469
-48
-9% -$24.6K 0.05% 385
2025
Q4 		$291K Buy
+517
New +$293K 0.06% 310

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

PCM Encore's MEDP Position: Q2 2026 in Review

PCM Encore reduced its Medpace (MEDP) stake by 0.85% in Q2 2026, selling an estimated $1.85K and leaving 465 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #383.

PCM Encore first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $291K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • PCM Encore held 465 shares of Medpace worth $246K as of Q2 2026.
  • PCM Encore sold 4 Medpace shares in Q2 2026, an estimated $1.85K.
  • Medpace made up 0.04% of PCM Encore's portfolio in Q2 2026, its #383 holding.
  • PCM Encore first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • PCM Encore's Medpace position peaked at $291K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.